Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New 'Bottom-Up' surgery for rectal cancer could mean faster recovery

NCT ID NCT02584985

First seen Apr 23, 2026 · Last updated Jun 22, 2026 · Updated 12 times

Summary

This study tested a newer, less invasive surgery called ETAP (done through the anus) against standard laparoscopic surgery (done through the belly) for low rectal cancer. 226 adults took part. The goal was to see if ETAP is as good at removing all cancer while possibly leading to fewer complications and a quicker recovery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Institut Paoli-Calmettes

    Marseille, 13009, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Endoscopic Transanal Proctectomy (ETAP) surgery

What this could lead to

If successful, ETAP could offer a less invasive surgical option for low rectal cancer with fewer complications and better recovery.

What could go wrong

This is a completed trial, but results may not apply to all patients. The new technique may not be as effective at removing all cancer or could have unknown long-term risks.

Conditions

The condition(s) this trial relates to.

rectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.